IndraLab

Statements



reach
"Treatment with the oxidant o-IBZ, resulted in a substantial increase in the relative sulfenic acid content of purified recombinant JAK1, as compared to that of JAK1 which was treated with the reducing agent DTT (XREF_FIG)."